← All companies

ORIC

ORIC Pharmaceuticals, Inc.

ORIC Nasdaq Pharmaceutical Preparations EDGAR ↗

$10.60

-1.04 -8.93%

Key statistics

from XBRL data in SEC filings

Market cap

$1.10B

Revenue (TTM)

—

Net income (TTM)

-$140M

EPS (TTM)

$-1.30

P/E ratio

—

Dividend yield

—

Free cash flow

-$112M

Cash

$37.5M

Total assets

$405M

Gross margin

—

52-week range

$7.23 – $14.93

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Results of operations (earnings release) Aug 3, 2026 8-K Director or officer change Jul 30, 2026 8-K Director or officer change; Shareholder vote results Jun 22, 2026 10-Q Quarter ended 2026-03-31 May 4, 2026 8-K Results of operations (earnings release) May 4, 2026 8-K Other events Mar 31, 2026 8-K Other events Feb 23, 2026 10-K Fiscal year ended 2025-12-31 Feb 23, 2026 8-K Results of operations (earnings release) Feb 23, 2026 8-K Other events Dec 8, 2025 8-K Regulation FD disclosure Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release); Exit or disposal costs Aug 12, 2025 8-K Shareholder vote results Jun 13, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events May 28, 2025 10-Q Quarter ended 2025-03-31 May 5, 2025 8-K Results of operations (earnings release) May 5, 2025 8-K Director or officer change Mar 14, 2025 8-K Other events Feb 25, 2025 10-K Fiscal year ended 2024-12-31 Feb 18, 2025 8-K Results of operations (earnings release) Feb 18, 2025 8-K Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release) Aug 12, 2024 8-K Shareholder vote results Jun 14, 2024 10-Q Quarter ended 2024-03-31 May 6, 2024 8-K Results of operations (earnings release) May 6, 2024 8-K Director or officer change Mar 29, 2024 10-K Fiscal year ended 2023-12-31 Mar 11, 2024 8-K Results of operations (earnings release) Mar 11, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jan 22, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 9, 2024 8-K Other events Dec 11, 2023 10-Q Quarter ended 2023-09-30 Nov 6, 2023 8-K Results of operations (earnings release) Nov 6, 2023